Igor B. Sivaev

Cyclic oxonium derivatives of polyhedral boron hydrides and their synthetic applications.

Cyclic oxonium derivatives of polyhedral boron hydrides are a relatively new class of boron compounds. They have great potential for the modification of various types of organic and bioorganic molecules and the synthesis of compounds that could be used in different fields from the treatment of nuclear wastes to the treatment of cancer. In the present Perspective we would like to present an overview of the results of the preparation and synthetic application of these compounds.

Derivatives of the closo-dodecaborate anion and their application in medicine

The paper presents a comparative analysis of the possibilities and characteristic features of the application of various polyhedral boron compounds, viz., the closo-decaborate anion [B10H10]2–, the closo-dodecaborate anion [B12H12]2–, the carba-closo-dodecaborate anion [CB11H12]–, carboranes C2B10H12, and the bis(dicarbollide) complexes [M(C2B9H11)2]– (M = Fe, Co, or Ni), in boron neutron capture therapy (BNCT) for cancer. The requirements on compounds used in BNCT are formulated and the advantages of the application of the closo-dodecaborate anion are considered. The data on the synthesis of various derivatives of the closo-dodecaborate anion, which either already found use in BNCT or are most promising in this field, are summarized. The possibilities of the application of agents derived from the closo-dodecaborate anion in medical diagnostics are discussed.

Chemistry of nickel and iron bis(dicarbollides). A review

Abstract Synthesis and chemical properties of nickel and iron bis(dicarbollides) and their derivatives are reviewed. A review with 81 references.

Crown Compounds for Anions: Sandwich and Half-Sandwich Complexes of Cyclic Trimeric Perfluoro-o-phenylenemercury with Polyhedralcloso-[B10H10]2− andcloso-[B12H12]2− Anions

It has been shown by IR and NMR spectroscopy that cyclic trimeric perfluoro-o-phenylenemercury (o-C6F4-Hg)3 (1) is capable of binding closo-[B10H10]2- and closo-[B12H12]2- anions to form complexes [[(o-C6F4Hg)3](B10-H10)]2- (2), [[(o-C6F4Hg)3]2(B10H10)]2-(3), [[(o-C6F4Hg)3](B12H12)]2- (4), and [[(o-C6F4Hg)3]2(B12H12)]2- (5). According to IR data, the bonding of the [B10H10]2- and [B12H12]2- ions to the macrocycle in these complexes is accomplished through the formation of B-H-Hg bridges. Complexes 2, 3, and 5 have been isolated in analytically pure form and have been characterized by spectroscopic means. X-ray diffraction studies of 3 and 5 have revealed that these compounds have unusual sandwich structures, in which the polyhedral di-anion is located between the planes of two molecules of 1 and is bonded to each of them through two types of B-H-Hg bridges. One type is the simultaneous coordination of a B-H group to all three Hg atoms of the macrocycle. The other type is the coordination of a B-H group to a single Hg atom of the cycle. According to X-ray diffraction data, complex 2 has an analogous but half-sandwich structure. The obtained complexes 2-5 are quite stable; their stability constants in THF/acetone (1:1) at 20 degrees C have been determined as 1.0 x 10(2)Lmol(-1), 2.6 x 10(3)L(2)mol(2), 0.7 x 10(2)Lmol(-1), and 0.98 x 10(3)L(2)mol(-2), respectively.

Cobalt bis(dicarbollide) versus closo-dodecaborate in boronated chlorin e6 conjugates: implications for photodynamic and boron-neutron capture therapy

Conjugation of boron nanoparticles with porphyrins is an attractive way to create dual agents for anticancer boron neutron capture therapy (BNCT) and photodynamic therapy (PDT). Properties of chlorin e(6) conjugated with two cobalt bis(dicarbollide) nanoparticles (1) or with a closo-dodecaborate nanoparticle (2) are reported. Fluorescent dianionic conjugates 1 and 2 penetrate in A549 human lung adenocarcinoma cells, stain cytoplasm diffusely and accumulate highly in lysosomes but are not toxic themselves for cells. Average cytoplasmic concentration of boron atoms (B) achieves 270 μM (ca. 2 × 10(8) B/cell) and 27 μM (ca. 2 × 10(7) B/cell) at the 1.5 μM extracellular concentration of 1 and 2, respectively, that makes conjugate 1 especially suitable for BNCT. Conjugate 2 causes photoinduced cell death at micromolar concentrations and can be considered also as a photosensitizer for PDT. Conjugates 1 and 2 have high quantum yields of singlet oxygen generation (0.55 and 0.85 in solution, respectively), identical intracellular localization and similar lipid-like microenvironment but conjugate 1 possesses no photoinduced cytotoxicity. A presence of cobalt complexes in conjugate 1 is supposed to be a reason of the observed antioxidative effect in cellular environment, but an exact mechanism of this intriguing phenomenon is unclear. Due to increased intracellular accumulation and absence of photoinduced cytotoxicity conjugate 1 is promising for fluorescence diagnostics of cancer.

Radiobromination of closo-dodecaborate anion. Aspects of labelling chemistry in aqueous solution using Chloramine-T

Summary Closo-dodecaborate dianion is a three-dimensional aromatic inorganic molecule, which can be easily halogenated forming a stable halogen-boron bond. Derivatives of closo-dodecaborate were considered as a convenient chemical form of delivery of enriched 10B to malignant tumors for boron neutron capture therapy (BNCT). Some properties of closo-dodecaborate (hydrophilicity, strength of halogen-boron bond, charge at lysosomal pH) make it attractive as a potential prosthetic group for attachment of radioactive halogens to tumor-targeting proteins. Bromine radioisotopes possess a variety of useful nuclear characteristics, and can be used in different areas of clinical diagnostics and therapy. In this work, a basic chemistry of closo-dodecaborate radiobromination was studied. It was found, that di(triethylamonium) dodecahydro-closo-dodecaborate can be labelled in high yield, more then 90%, in a wide pH range. By decreasing the pH, the bromination can be directed to closo-dodecaborate in the presence of phenolic compounds. The results of the study indicate a possibility of using the radioactive bromine label for investigation of pharmacokinetics of boronated compounds for BNCT.

Dihydrogen bonding of decahydro-closo-decaborate(2−) and dodecahydro-closo-dodecaborate(2−) anions with proton donors: experimental and theoretical investigation

Abstract The interactions of [Bu 4 N] 2 [B 10 H 10 ] and [Bu 4 N] 2 [B 12 H 12 ] with various proton donors (MeOH, EtOH, Pr i OH, PhOH, 4-FC 6 H 4 OH, 4-NO 2 C 6 H 4 OH, CF 3 CH 2 OH, (CF 3 ) 2 CHOH, (CF 3 ) 3 COH) in low polarity media were investigated. The site of coordination for [B 10 H 10 ] 2− and [B 12 H 12 ] 2− was found to be hydride hydrogen. Spectral (IR, NMR) evidences for the BH⋯HO hydrogen bonding between the boron hydrides and the OH proton donors in solution are presented. Spectral (Δ ν , Δ ν 1/2 , ΔA) and thermodynamic (Δ H °, Δ S °) characteristics of the H-complexes were determined. The BH⋯HO bonding strength increases from [B 12 H 12 ] 2− to [B 10 H 10 ] 2− . The geometry, energy, as well as electron distribution in the [B 10 H 10 ] 2− ·HOCH 3 , [B 10 H 10 ] 2− ·HOCF 3 , [B 10 H 10 ] 2− ·HCN, and [B 12 H 12 ] 2− ·HOCH 3 complexes were studied using ab initio HF/6-31G approximation. It was shown that increase of the proton donor ability of acids leads to formation of bifurcate H-bonds.

New approach to incorporation of boron in tumor-seeking molecules.

Cyclic oxonium derivatives of polyhedral boron hydrides have great potential for modification of various types of tumor seeking biomolecules and are very promising starting materials for synthesis of BNCT (boron neutron capture therapy) agents.

Syntheses, structures, and electroconductivity of bis(ethylenedithio)tetrathiafulvalene (BEDT-TTF) and bis(methylenedithio)tetrathiafulvalene (BMDT-TTF) salts with cobalt 8,8′-dichloro-3,3′-bis(1,2-dicarbollide)

Radical cation salts of bis(ethylenedithio)tetrathiafulvalene (BEDT-TTF) and bis(methylenedithio)tetrathiafulvalene (BMDT-TTF) with the 8,8′-dichloro derivative of cobalt bis(1,2-dicarbollide) (BEDT-TTF)2[8,8′-Cl2-3,3′-Co(1,2-C2B9H10)2] (1) and (BMDT-TTF)4[8,8′-Cl2-3,3′-Co(1,2-C2B9H10)2] (2) were synthesized and their crystal structures and electrocon-ducting properties were determined. The synthesized radical cation salts are semiconductors with the conductivity σ293 = 1.5 and 2.0 Ohm−1 cm−1, respectively. A decrease in the size of the substituent in a series of (BEDT-TTF)2[8,8′-X2-3,3′-Co(1,2-C2B9H10)2] and (BMDT-TTF)4[8,8′-X2-3,3′-Co(1,2-C2B9H10)2] (X = I, Br, Cl) results in the compression of the anion sublattice of the crystal and compaction of the radical cation packing of the conducting layer, which, in turn, increases the conductivity of the crystals.

A universal approach to the synthesis of carbohydrate conjugates of polyhedral boron compounds as potential agents for boron neutron capture therapy

A universal approach to the synthesis of carbohydrate conjugates with polyhedral boron compounds (PBCs) was developed. Oligosaccharide derivatives with amino group in aglycone moiety can be conjugated with PBC carboxy derivatives using N-methyl-N-(4,6-dimethoxy-1,3,5-triazin-2-yl)morpholinium chloride as a condensing agent. Both N-and O-glycosides differing in the conformation mobility around the glycoside bond were shown to be useful as oligosaccharides with a functional group in the aglycone moiety. This allows the application of this approach to the synthesis of PBC conjugates with a wide range of oligosaccharides isolated from natural sources can be transformed into N-glycosides with a functional group in aglycone. The approach was tested by conjugation of the carboxy derivatives of ortho-carborane and dodecaborate anion with lactose as a model oligosaccharide. Lactose, an easily available disaccharide, is a ligand of lectins expressed on the surface of melanoma cells. The approach suggested is the first example of the synthesis of such conjugates that does not require protective groups for the carbohydrate residue. It is especially important for obtaining dodecaborate-carbohydrate conjugates for which the removal of protective groups is often a non-trivial task.